Indeed, FTase inhibitors (FTIs) improve nuclear shape abnormalities of LMNA‐ and Zmpste24‐mutant cells and clinical phenotypes in HGPS patients (Gordon et al., 2018; Young et al., 2005). Here, ZMPSTE24 is linked to Hutchinson-Gilford progeria syndrome.